LDPath, the UK’s Leading Diagnostics Provider, Expands AI Capabilities with Ibex Medical Analytics
NHS trusts have access to Galen, Ibex’s multi-tissue AI platform, which supports pathologists with improved diagnostic accuracy and efficiency TEL AVIV, Israeland LONDON, December 7, 2022 /PRNewswire/ — Ibex Medical Analytics (Ibex), the leader in AI-based cancer diagnostics and Source LDPath, a subsidiary of Source BioScience (Source), a leading international provider of integrated laboratory services …